mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
BHG712 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.02 |